Visual analysis of the top 20 pathways showed that the main signaling pathways of SCDP in the treatment of UC were concentrated in pathways in cancer, the advanced glycation end products and the receptor for AGEs (AGE-RAGE) signaling pathway in diabetic complications, bladder cancer, IL-17 signaling pathway, apoptosis, p53 signaling pathway, and phosphoinositide 3-kinase (PI3K)-Akt signaling pathway (Figure 5). The gene discussed is TP53; the disease is urinary bladder cancer.